AzTrials
AzTrials

Well-being/Quality of LifeNCT07400081

Effectiveness of a Community-based Intervention Programme to Promote Well-being in Older Adults

A study testing Community-based Intervention in people with Well-being/Quality of Life and Mental Health, run by National Healthcare Group Polyclinics at 1 site in Singapore.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study is conducted to assess the effectiveness of a community intervention programme on improving well-being, levels of distress, and loneliness in older adults (aged 55 years old and above), who have symptoms of depression. Social Service Agencies (SSAs) will conduct focal talks on well-being for the community. Read more about this study

Who is it for?
Ages 55 years and olderHealthy volunteers can take part
Conditions the study is for
Well-being/Quality of Life, Mental Health
What is being tested?
Community-based Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteSingapore
Study dates
Mar 2026to Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Aged 55 and above
  • Score of 1-9 on the PHQ-9 questionnaire
  • Able to speak and understand English, Chinese or Malay
  • Able to provide informed consent
  • Be willing to use common technologies (such as phone calls, texting via SMS/whatsapp) for communication

Who cannot join

  • PHQ-9 score of 0
  • PHQ-9 score of 10 or more
  • Actively being followed up by a mental health professional
  • On psychotropic medication or are undergoing psychotherapy
  • Have other mental disorders or are suicidal
  • Have physical difficulties, cognitive impairment or difficulties with speech, sight and hearing or mobility that may prevent their engagement in activities

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Singapore1 site
  • National Healthcare Group Polyclinics

    Singapore, Singapore, 308205

    Eugene YC Chua, +6563553000, eugene.yc.chua@nhghealth.com.sg

Other trials in Singapore

About this study

This study is conducted to assess the effectiveness of a community intervention programme on improving well-being, levels of distress, and loneliness in older adults (aged 55 years old and above), who have symptoms of depression.

Social Service Agencies (SSAs) will conduct focal talks on well-being for the community. As part of the focal talks, the Public Health Questionnaire-9 (PHQ-9) will be conducted. Attendees with a PHQ-9 score of 1-9 will be invited to take part in the study. Up to 300 participants will be recruited and randomised into 2 arms: control arm (150 participants) and intervention arm (150 participants).

Participants in the intervention arm will undergo 8-week community intervention programme which includes 4 sessions on well-being and continuous follow-up with a Health Companion. Participants in the control arm will be offered to join a programme conducted by the SSAs 8 weeks after recruitment into the study. The programmes offered to the control group are independent of the study.

Read the detailed description

Study Procedures:

Control arm: Participants randomised into the control arm will not be offered any programmes for 8 weeks after their recruitment into the study. After 8 weeks, the SSAs will offer the participants an intervention programme that is independent of the study.

Intervention arm: Participant in the intervention arm will undergo 4 face-to-face, group psychoeducation sessions, conducted fortnightly over a period of 8 weeks. The sessions will teach the participants about well-being and share with them strategies to improve their well-being. Health Companions from the SSAs will conduct check-ins with the participants over the phone, and recommend some nearby activities for them.

Methods and assessments:

Questionnaires including the 6-item De Jong Gierveld Loneliness Scale, Warwick-Edinburgh Mental Wellbeing Scale, Patient Health Questionnaire-9, and Generalised Anxiety Disorder-7 at the baseline and endpoint for all participants.

Expected risks:

During the administration of the questionnaires, participants may feel uncomfortable or upset. Participants may choose to refuse to asnwer any of the questions, or take a break at any time during the questionnaire administration.

Participants in the intervention arm may feel discomfort, anxiousness or distress while undergoing the intervention programme. Participants may cease their enrolment in the study, or be encouraged to attend clinical follow-ups or reach out to the Social Service Agencies' Community Intervention Team (COMIT).

Safety Review Plan:

As this study does not involve any invasive procedures, the study team does not foresee any adverse events related to the study.

Data Quality Assurance:

The PI or study team member will review all data collection forms on an ongoing basis for data completeness, accuracy and protocol compliance, after every data collection timepoint.

Data entry and storage:

For hardcopy data, they will be stored in designated locked cabinet(s) or room(s) that are accessible to authorized study personnel only. For electronic data, they will be stored on in a secured computer that is password protected. The databases will not contain subject identifiers and the data linking subject identifiers and the subject identification codes will be stored separately.

Sample size calculation:

An a priori power analysis was conducted to determine the required sample size for detecting a statistically significant difference in the primary outcome, the Warwick-Edinburgh Mental Well-being Scale (WEMWBS), between the intervention and control arms. The effect size based on standardised mean differences (SMD) for this calculation was informed by a comprehensive systematic review by Blodgett et al. (2022), which reported a medium to large range of SMD from 0.38 to 0.72 for selected themes and subthemes of intervention across studies. To ensure the study is adequately powered for a conservative estimate, the smallest effect size from this range, d = 0.38, was used for the calculation. The power analysis was performed for a two-tailed independent samples t-test using the pwr package in R, with a standard significance level (α) of 0.05 and a desired power (1-β) of 0.80. The results indicated that a minimum of 110 participants per group is required. To account for a potential 20% attrition rate, the minimum recruitment target is about 130 participants per arm. The study team rounded up the number to 150 participants per arm, with a total of 300 participants to be recruited.

Statistical and analytical plans:

Data will be analysed using SPSS/Stata/R. Normality of the data will be checked using the Kolmogorov-Smirnov test. Differences between variables will be tested by t-test and Mann-Whitney U test for normal and non-normal continuous variables respectively and chi-square test or Fisher-exact test for categorical variables. Associations with the improvement in scores will be analysed via multivariable regressions. P value <0.05 will indicate statistical significance.

Being tested
Community-based Intervention
Keywords
Community-based intervention, Well-being, Older adults, Mental Health
Medical subject headings
Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Community-based InterventionBehavioural

    Psychoeducation Programme

Study groups in NCT07400081
Study groupRoleWhat they receive
ControlNo interventionWaitlist Control
InterventionOtherCommunity-based Intervention
Receives: Behavioral: Community-based Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Well-being

    Measured by Warwick-Edinburgh Mental Well-being Scale (WEMWBS) Minimum score: 7 Maximum score: 35 Higher scores indicate higher positive mental well-being (Better outcome).

    Measured: 8 weeks

Secondary outcomes (3)
  1. Depressive symptoms

    Measured by Patient Health Questionnaire-9 (PHQ-9) Minimum score: 0 Maximum score: 27

    Higher scores represent higher severity of the symptoms of depression (worse outcome).

    Specifically, scores of 0-4 represent none to minimal depression severity; scores of 5-9 represent mild depression severity; scores of 10-14 represent moderate depression; scores of 15-19 represent moderately severe depression; scores of 20-27 represent severe depression.

    Measured: 8 weeks

  2. Anxiety symptoms

    Measured by Generalised Anxiety Disorder-7 (GAD-7) Minimum score: 0 Maximum score: 21

    Higher scores represent higher severity of anxiety symptoms (worse outcome). Specifically, scores of 0-4 represent minimal anxiety; scores of 5-9 represent mild anxiety; scores of 10-14 represent moderate anxiety; scores of 15-21 represent severe anxiety.

    Measured: 8 weeks

  3. Loneliness

    Measured by De Jong Gierveld Loneliness Scale Minimum score: 0 Maximum score: 6 Higher scores represent higher severity of loneliness (worse outcome). Specifically, scores of 0-2 represent low levels of loneliness; scores of 3-4 represent moderate levels of loneliness; scores of 5-6 represent intense/severe levels of loneliness.

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2026
  2. Study startMar 2026 (estimated)
  3. Primary completionDec 2027 (estimated)
  4. Study completionDec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Community-based intervention through structured psychoeducation and social prescription
Masking
None (open label)
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07400081
Sponsor's protocol ID
2025-1289
Status last verified
Jan 2026
First submitted
3 Feb 2026
Last updated
13 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Community-based Intervention in people with Well-being/Quality of Life and Mental Health, run by National Healthcare Group Polyclinics at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eugene YC Chua (+6563553000, eugene.yc.chua@nhghealth.com.sg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Well-being (time frame: 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in